000 01364 a2200385 4500
005 20250515021539.0
264 0 _c20060508
008 200605s 0 0 fre d
022 _a0003-4509
024 7 _a10.1016/s0003-4509(06)75300-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMadoulet, Cl
245 0 0 _a[Anti-tumor immunotherapy against multidrug resistance].
_h[electronic resource]
260 _bAnnales pharmaceutiques francaises
_cMar 2006
300 _a87-96 p.
_bdigital
500 _aPublication Type: English Abstract; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAutoantibodies
_ximmunology
650 0 4 _aCell Line, Tumor
650 0 4 _aDrug Resistance, Multiple
_ximmunology
650 0 4 _aDrug Resistance, Neoplasm
_ximmunology
650 0 4 _aImmunization
650 0 4 _aImmunoglobulin G
_xadministration & dosage
650 0 4 _aImmunoglobulin M
_xadministration & dosage
650 0 4 _aImmunotherapy
650 0 4 _aLeukemia P388
_xdrug therapy
650 0 4 _aLiposomes
650 0 4 _aMice
650 0 4 _aNeoplasms
_xdrug therapy
700 1 _aPerrin, L
700 1 _aTosi, P F
700 1 _aAlbert, P
773 0 _tAnnales pharmaceutiques francaises
_gvol. 64
_gno. 2
_gp. 87-96
856 4 0 _uhttps://doi.org/10.1016/s0003-4509(06)75300-7
_zAvailable from publisher's website
999 _c16175320
_d16175320